Stroke Trial, Recruiting NCT06940635 Sponsor: VASCage GmbH Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06940635
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older.
  • People who had an ischemic or haemorrhagic (bleeding) stroke more than 3 months ago.
  • People who still have weakness or reduced movement in one arm as a result of their stroke.
  • People who have difficulty with speech or communication, and/or difficulty swallowing, as a result of their stroke.
  • People whose neurological condition (brain and nerve function) has been stable for the past 4 weeks, with no significant changes (based on self-report).
  • People who are able to pick up at least one small block with their hand.
  • People who are able to understand basic spoken instructions.
  • People who are able to sit upright for at least 60 minutes.
  • People who are willing to take part in the study and are able to understand and sign a consent form.

Who may not be able to join:

  • People whose thinking or memory difficulties, in the trial doctor's judgement, would prevent them from understanding task instructions.
  • People whose stroke affected the brainstem and/or cerebellum (areas at the lower back of the brain).
  • People who had a previous stroke that caused significant disability.
  • People who have a pronounced tendency to ignore one side of their body or environment (hemi-neglect), to a degree that the trial doctor judges would interfere with treatment.
  • People who have a pronounced lack of awareness of their own condition (anosognosia), to a degree that the trial doctor judges would interfere with treatment.
  • People who have severe muscle stiffness (spasticity) in the affected arm that results in the arm being completely rigid and unable to move.
  • People who have epilepsy that is not well controlled, or who have had a seizure in the past month.
  • People who are known to have raised pressure inside the skull (intracranial pressure) that is ongoing.
  • People who have an implanted medical device — such as a pacemaker — that is not compatible with functional electrical stimulation (FES, a type of treatment that uses small electrical pulses to activate muscles).
  • People who have metallic implants in the arm planned to receive FES treatment, in a location that would prevent the safe use of FES.
  • People who have unhealed bone fractures or open skin or tissue wounds in the arm planned to receive FES treatment.
  • People who have bone stiffening, joint tightening, or reduced movement in the wrist of the arm planned to receive FES treatment, to a degree that would limit treatment.
  • People who received botulinum toxin (commonly known as Botox) injections in the 6 weeks before joining the study, or for whom such treatment is planned during the study period.
  • People with very severe chronic lung disease (COPD Stage IV).
  • People with very severe heart failure (NYHA Stage IV).
  • People with a serious active infection.
  • People with significant problems with blood circulation in the arm planned for FES treatment.
  • People who have sensory problems that significantly reduce their ability to feel pain or respond to physical sensations in an appropriate way.
  • People with any other medical condition that, in the trial doctor's judgement, would affect their safety or ability to take part in study procedures.
  • People who are known to be unable to tolerate electrical stimulation applied to the skin.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael Knoflach, Assoc.-Prof., Medical University Innsbruck

Phone: +43 664 1004838

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
VASCage GmbH
Registry
ClinicalTrials.gov
Start date
4 June 2025
Est. completion
30 June 2026

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Change in Gugging Swallowing Screen (GUSS); Change in Bielefeld Aphasia Screening Reha (BIAS-R)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov